chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She started having fever like 101 and I give her Tylenol, it helped a little bit; she started having high fever again at around 5'Oclock came back around 102;  she is shivering a lot as well; She started having fever like 101 and I give her Tylenol, it helped a little bit; she started having high fever again at around 5'Oclock came back around 102; she is shivering a lot as well; She started having a lot of sweats; she felt warm and sweat; this morning she woke up kind of warm with 99.9; She started having a lot of sweats; she felt warm and sweat; this morning she woke up kind of warm with 99.9; she had also Diarrhea; This is a spontaneous report from a contactable consumer (patient's mother). A 23-year-old female patient received second dose of BNT162B2 (Solution for injection, NDC/UPC number: Unknown, Expiry date: Unknown) via an unspecified route of administration on 15Jun2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (at age of 23 years) for COVID-19 immunization and no reaction was reported on previous exposure to vaccine. On 15Jun2021, the patient started having a lot of sweats; she felt warm and sweat; and morning she woke up kind of warm with 99.9. She started having fever like 101 and was given TYLENOL (NDC/UPC number: Unknown, Expiry date: Unknown) which helped a little bit; she started having high fever again at around 5'O clock came back around 102; she was shivering a lot as well. She also had diarrhea and had taken her to the emergency room. Reporter stated, "her daughter had Pfizer, the second shot yesterday afternoon and last night she started having a lot of sweats. So, she felt warm and sweat which we thought was going to pass. But then, morning she woke up kind of warm with 99.9 and then she thought it was going to pass. But then she started having fever like 101 and she gave her TYLENOL (captured as suspect), it helped a little bit. But that afternoon she started having high fever again at around 5'O clock came back around 102. So, she took another 2 TYLENOLs, and it was already 10:17, was not sure, 10:25 and she just check out her temperatures she was 102.3. So, her question was should she take her to emergency room because she was shivering a lot as well". Reporter was requested to take the patient to the nearest emergency room or contact a healthcare provider. Reporter was informed to contact Pfizer Medical Information Department as well. However, the department was closed currently. Further probing could not be done as reporter did not want to share further information. Hence, limited information was available over the call. Reporter seriousness was reported as unspecified. Outcome of the event sweating and diarrhea was unknown, whereas other events was not recovered.  Information related to batch/Lot no. was requested.
Vaccine given 6/09/2008. Varicella like rash-diffuse. Papules, vesicular, pruritic trunk and legs began 9/20/08 for one week. New eruptions. No fever. No systemic symptoms.
Headache, Myalgia & Arthralgia Narrative: Neck pain, headache, arm pain at injection site. Took Tylenol.
I had been quite tired for about six months. I went to the doctor's office on 3/1/2023, because my fatigue was so great that it put me in bed for about six days. I had taken a COVID-19 test and gotten a negative result. The doctor did bloodwork, and a couple of days later, the results came in. My ferritin level was only 5! I was treated for the low ferritin by undergoing two iron infusions. I felt quite a bit of difference after the first infusion and even more after the second, but it took about three weeks for it to really kick in. On 3/14/2023, I underwent more bloodwork, and my ferritin was 136. I feel like I'm doing really well now. I feel that the infusions turned things around quite a bit. The doctors didn't find any discernable reason for the low ferritin level.
Patient called this am c/o pain and redness at injection site late last night after recieveing Pneumococcal vaccine 8/25/09@ 1130 am.                                      VET CALLS BACK TO CLINIC REPORTING ON HER CONDITION AFTER PNEUMO. VAX SHOT. SHE  REPORTS SHE HAS REDNESS IN A NEW AREA ON HER ARM ABOUT THE SIZE OF A FIST. SHE  SAID IT IS ALSO SWOLLEN IN THAT AREA. SHE REPORTS HOWEVER THAT THE PAIN IS LESS  THAN IT WAS YESTERDAY AFTER SHE STARTED USING MOTRIN 600MG TIID WITH FOOD AND  COOL COMPRESSES. I TOLD HER THAT SINCE THE PAIN IS LESS I THOUGHT SHE COULD WAIT  TO REPORT BACK TO ME TOMORROW ON HER CONDITION. SHE WILL CALL ME BACK.
Started with raised, red, hive-like rash on back of legs and trunk.  Took benadryl that evening - the next morning the rash on the back of my legs and trunk was gone but I had new hives on the insides of my forearms, knees and calves.  It responded well to benadryl  (took a does on the morning and before bed on 4/08/2021.)  It appears to all be gone at the time of submission (morning of 4/9/2021).  No fever, aches or other symptoms were present.
Site: Swelling at Injection Site-Medium, Systemic: RIGHT ARM SWOLLEN SINCE THE DAY OF THE VACCINE.-Medium, Additional Details: RIGHT ARM SWOLLEN SINCE THE DAY OF VACCINE, PATIENT WILL BE SCHEDULING AN APPOINTMENT WITH PCP.
Asthma, conjunctivitis, cough increased, dyspnea. Initial report extracted from VAERS database via QSCAN report on 11 March 2009 (VAERS identification number 245175). A 46 year old female patient had received on 29 September 2005 a second intramuscular injection of FLUZONE SV 20005-2006 (lot number U1778AA). It was reported the patient developed a cough, wheezing, shortness of breath and red irritated eyes. It was not reported whether any relevant diagnostic tests or laboratory data were performed. Treatment was not reported. VAERS coded the events as asthma, conjunctivitis, increasing cough and dyspnea. The patient recovered.
very large swelling and high temperature at site of injection. Difficult Breathing, wheezing, fast heart beat. Blood preasure 130 over 87  Patient refused to seek medical attention. "I had a reaction like this seven years ago and should not have gotten the shot. I will live."
Pain to Elbow to neck, red blotching to arm, hot to the touch. Patient took BENADRYL, and blotches went away in 24 hours and pain subsided within 48 hours.
Information has been received from a Immunization manager concerning a 66 year old female who on 10-AUG-2009 was inadvertently vaccinated with a dose of VARIVAX (Merck) (lot#, route and site of administration not reported) instead of ZOSTAVAX (Merck). No symptoms reported. No medical attention was sought. The patient's outcome was unknown. Additional information has been requested.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding medical history, concurrent conditions, and concomitant medications. On or about 17-APR-2014, the patient received ZOSTAVAX for its intended purpose: the prevention of shingles. As a direct result of the vaccine, the patient suffered from a shingles outbreak, in addition to chronic pain, rash, and lesions to various parts of his body. The patient did not have a shingles outbreak until 26-JUN-2017.  As a direct result of ZOSTAVAX, the patient suffered mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, he suffered serious, progressive, permanent and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The outcome of the event was unknown at the time of reporting.  Causality assessment was related. The lawyer considered shingles outbreak/chronic pain, rash and lesions to various parts of his body to be disabling. Additional information has been requested.
it was oozing out like some white moisture or something; Sore arm; Another spot on my back about a inch lower than the one that was before and it is red again, looks like a blister under my skin; A blister come up under my skin; It was red and it was itchy; It was red and it was itchy; This is a spontaneous report from a contactable consumer (patient).  A 61-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EN6207; Expiration Date: Jul2021), via an unspecified route of administration, administered in Arm on an unspecified date as dose number unknown, single for covid-19 immunisation. Medical history included diabetes mellitus, hypertension. Patient reported that got the Pfizer shot at 11:50 on Friday and yesterday down towards shoulder got like a blister come up under skin, it looked like a blister and then patient rubbed it, it burned real bad and then patient put some alcohol on it and it went away, it was red and it was itchy and it was oozing out like some white moisture or something which patient don't know, it look like what comes out of a blister. Patient went to sleep last night, there was no shortness of breath, patient got sore arm like they said and then it is gone away and no other reaction. But again today, patient got another spot on back about a inch lower than the one that was before and it is red again, looks like a blister under patient skin and it is red. The patient underwent unknown laboratory tes.t with unknown result. The outcome of the event was Not recovered.  No follow-up attempts are possible. No further information is expected.
Information has been received from a licensed practical nurse concerning a 4 year old female patient with no drug reactions/allergies and no pertinent medical history who on 01-JUN-2009 was vaccinated SQ with the first 0.5 mL dose of VARIVAX (Merck) (lot #663543/0122Y).   Concomitant vaccines included DTAP, MMR II (MSD) and poliovirus vaccine.  On 01-JUN-2009, the patient experienced vomiting, fever and swollen arms later that night.  Her doctor prescribed her TYLENOL, ordered sips of water and cool compresses to the arms.  Laboratory tests were not performed.  On an unspecified date the patient recovered.  On 30-JUN-2009, the patient received her second 0.5 mL dose of VARIVAX (Merck) (lot # 663543/0122Y), subcutaneous route, and no adverse symptoms were noted.  The patient sought unspecified medical attention.  Follow up information has been received from the licensed practical nurse concerning this 4 year old minor female who on 01-JUN-2009 at 3:59 pm was vaccinated SQ in her left upper arm with the first 0.5 mL dose of VARIVAX (Merck) (lot # 663543/0122Y).  Concomitant vaccines administered on the same day included a fourth dose of DTAP (lot # C3084AA, IM, right deltoid lower arm, at 3:54 pm), a fourth dose of poliovirus vaccine (lot # B0475, IM, right deltoid, at 3:56 pm) and MMR II (MSD) (lot # 663668/ 0114Y, SQ, left lower arm, at 4:01 pm).  On 02-JUN-2009, in the early morning, the patient experienced vomiting, fever, swollen arms and she felt thirsty. The patient was treated with TYLENOL suppository, and on an unknown date the patient recovered.  Additional information is not expected.
Flu like symptoms; Ache; Rash around injection site; Feverish; Tired; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Ache), INJECTION SITE RASH (Rash around injection site), PYREXIA (Feverish) and FATIGUE (Tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Ache), INJECTION SITE RASH (Rash around injection site), PYREXIA (Feverish) and FATIGUE (Tired). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Ache), INJECTION SITE RASH (Rash around injection site), PYREXIA (Feverish) and FATIGUE (Tired) outcome was unknown.            The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable  No concomitant medications were reported  No treatment drugs were reported   This case was linked to MOD-2021-138588 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: New events(Flu like symptoms, pain and Rash at injection site) were added, patient age updated
Patient experienced within an hour of flu vaccination: palpitations, fatigue, and diarrhea
BRIEF OVERVIEW: Admission Date: 8/13/2023 Discharge Date: Aug 15, 2023 Discharge Disposition:  skilled nursing facility  DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute cystitis without hematuria [N30.00] Acute COVID-19 [U07.1] COVID-19 [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82]   HOSPITAL COURSE: Patient is an 84-year-old female with a past medical history of recurrent urinary tract infection, dementia, rheumatoid arthritis on methotrexate, anemia, GERD and anxiety who presented with a chief complaint of low oxygen levels from her facility.  She was recently diagnosed with a urinary tract infection on 07/26/2023 and treated with a course of antibiotics.  She was then diagnosed with COVID-19 on 08/07/2023 and completed a course hepatic flow void of the day prior to admission.  She was sent from her facility to the emergency department due to low oxygen levels at 80% on pulse ox.  In the emergency department she was tachypneic and hypoxic.  She required 3 L nasal cannula.  Labs were unremarkable, including CMP and complete blood count which showed chronic anemia.  BNP was normal, but toward the upper limits of norma.  UA with positive for possible infection, but showed 7 squamous cells.  EKG showed artifact, but did show a prolonged QTC.  Chest x-ray showed volume loss of the left hemithorax consistent with partial left pneumonectomy and blunting of the left costophrenic sulcus.  She was given Rocephin for possible urinary tract infection and dexamethasone for COVID-19 infection.  She was admitted to the hospitalist service for COVID-19 pneumonia.   At admission, she was started on Decadron and remdesivir IV.  She was having difficulty with maintaining her oxygen on due to agitation in the setting of her dementia, but she tolerated leading to room air on 08/14/2023.     Rocephin was discontinued as she did not have symptoms of a urinary tract infection and was not septic appearing.  She was very recently treated for urinary tract infection.    8/15:  one blood culture bottle from admission was positive for CNS and this was felt to be a contaminant given her overall clinical improvement. patient was able to be weaned to room air almost immediately and remained stable after improvement, subsequently she was cleared for discharge; because she was able to be weaned to room air so quickly and maintained her saturations it was decided that she would not need to be discharged on steroids. at the time of discharge patient was in good spirits and eager to leave. all questions and concerns addressed, all meds and follow-ups reviewed. per CM family updated prior to discharge.
pt recv vax SEP95 & pt devel chronic cough;no further details were provided;
had a bad reaction; This case was reported by a nurse via call center representative and described the occurrence of nonspecific reaction in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced nonspecific reaction. On an unknown date, the outcome of the nonspecific reaction was recovered/resolved.   It was unknown if the reporter considered the nonspecific reaction to be related to Shingrix.  Additional case details were reported as follows: This case was reported by a retired nurse for her friend. The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The reporter stated, the patient had a bad reaction to Shingrix dose and was better in 2 days.   The reporter did not have specific details on what the reaction was. The reporter gave permission to follow up.
Immediately after as I was walking toward the waiting seating area I had a pounding rapid heart beat, and as I was walking toward the car I could not keep up with my friend I was having shortness of breath and rapid heart beat. By the end of the night I went to a care center and was instructed if it continues to go to the emergency room.  I  see my cardiologist on the regular due to a history of tachycardia, most recent visit was in 3/2023. (cardiologist listed as provider on form Dr.)  I was temporality put on aliquots.
Limited range of motion of left arm, pain, frozen shoulder thus far treatment is physical therapy, but surgery is recommended.
Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Fever-Medium, Systemic: Headache-Medium
This spontaneous report was received from a licensed nurse practitioner and refers to multiple patients of unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant therapy were not reported. On 22-SEP-2016 or 23-SEP-2016, the patients were inadvertently vaccinated with an improperly stored dose of VAQTA (dose, route of administration, lot # and expiration date were not reported). The administered doses of vaccines were exposed to a temperature of 1 Celsius degrees, for 1 hour and 46 minutes. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
p/4-5 days of receiving vax pt c/o tenderness @ site, reddness & swelling rt arm; tx consisted of ice, Ibuprofen or APAP; (4x5 size induration & erythema);
After about 10 minutes my arms had red splotches on them, my face turned red and my tongue and neck felt swollen.
Information has been received from a physician and a practice manager via company representatives referring to a patient of unknown age and gender. On 21-JAN-2014, the patient was vaccinated with an improperly stored dose of VAQTA, lot # J006521, expiration date 23-AUG-2015 (dose and route unspecified). This specified lot number vaccine was exposed to temperature excursions for two times. The storage criteria and the type of excursion (R/F) were refrigerator (R). The lowest recorded temperature (Fahrenheit degree (F)) and total cumulative excursion time (hour) were as following: 33 F for 92 hours and 34 F for 28 hours. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Fever 103.3 Dizziness  Nausea Left arm pain  Fatigue
The patient shortly lost consciousness and was seizing a few minutes after receiving the covid-19 vaccine.  Once he regained consciousness he was able to talk clearly.  He said his head hurt a bit.  He was given the okay to go home by the paramedics after examining the patient.
pt recv vax 16OCT96 & 3DEC96 pt exp fever, sore throat, cough, muscles aches & fatigue for 2 1/2wk;pt has not yet recovered;pt indicated had been vaccinated w/one of the recalled lot, but unable to ID specific lot#;
cardiac arrest, ventricular fibrillation, new large brain aneurysm. anoxic brain injury.  She was found in her car down with cardiac arrest in ventricular fibrillation. She was intubated and found to have brain aneurysm that is new. She suffered anoxic brain injury and was in vegetative state. aneurysm is left alone due to poor neurologic function per neurosurgery.  Pt is placed on comfort care and waiting for expiration
Patient was found unresponsive, diaphoretic, but with a pulse. As the clinical supervisor, I checked his pulse and started to provide a sternal rub. He then started to become responsive. He was able to verbalize who he was and paramedics arrived on the scene. They had him lay on a cot and began to take his blood pressure, pulse, and pulse oximetry. They then checked his blood sugar. Patient was able to sit up and started feeling better.
11/28/07 in with rash R arm 3-4cm of multiple vesicles, area around rash erythematous & edematous up to approx 8 cm.  Skin taut & warm to touch.  Advised to take to MD today for evaluation.
This study case was received from the investigator (MILVAX) on 02 May 2012. A 46-year-old male subject with a past medical history of high blood pressure, elevated cholesterol, shortness of breath, asthma and headaches was diagnosed with other and unspecified angina pectoris three days after the subject had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 03 February 2012. The subject's ECG was normal on 06 February 2012. Results of the echocardiogram were not available. No further information was available at the time of the report. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: None.
One hour after administration adverse events noticed: major headache that continued on and off for 7+ days, metallic taste with fullness of throat on and off for a few days, following day neck and upper shoulder soreness on and off for 7 + days, general fatigue on and off for 7+ days